 Monoclonal anti-T cell antibody treatment graft-versus-host disease severe combined immunodeficiency targeting antibody activation complement cytotoxic cell surfaces male child severe immunodeficiency unirradiated blood transfusion acute severe graft-versus-host disease GVHD monoclonal anti-T cell antibody treatment GVHD confluent maculopapular rash liver function tests skin biopsy Separation peripheral blood mononuclear cells rosettes sheep red blood cells engrafted cells nonrelated HLA type blood donor patient intravenous monoclonal dose mg/kg/day days vivo effect clinical improvement skin rash return liver normal range human complement components fluorescence microscopy surfaces engrafted skin biopsy specimens biotin-avadin assay presence cells studies vivo targeting monoclonal antibody cells GVHD activation complement cells